Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

Innovative Medical

Status and phase: Completed; Phase 4

Conditions: Glaucoma

Treatments: Drug: Bimatoprost 0.03%, Travoprost 0.004%

Study type: Interventional

Funder types: Industry

Identifiers

NCT00347802

5176

Details and patient eligibility

About

To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• · Male or female > 18 years of age

  • Naive to treatment or washed off any ocular hypotensive agents
  • Untreated IOP >19 mm Hg
  • Diagnosis of open-angle glaucoma or ocular hypertension
  • Ability to provide informed consent and likely to complete study

Exclusion criteria

• · Known contraindication to bimatoprost or travoprost, or any component of any study medication

  • Uncontrolled systemic disease
  • Active ocular disease other than glaucoma or ocular hypertension
  • Required use of ocular medications other than the study medications during the study
  • History of intraocular surgery within the last 3 months
  • Prior discontinuation of any of the study medications for reasons related to efficacy or safety